640 related articles for article (PubMed ID: 26425694)
1. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
Procopio FA; Fromentin R; Kulpa DA; Brehm JH; Bebin AG; Strain MC; Richman DD; O'Doherty U; Palmer S; Hecht FM; Hoh R; Barnard RJ; Miller MD; Hazuda DJ; Deeks SG; Sékaly RP; Chomont N
EBioMedicine; 2015 Aug; 2(8):874-83. PubMed ID: 26425694
[TBL] [Abstract][Full Text] [Related]
2. TILDA: Tat/Rev Induced Limiting Dilution Assay.
Lungu C; Procopio FA
Methods Mol Biol; 2022; 2407():365-372. PubMed ID: 34985676
[TBL] [Abstract][Full Text] [Related]
3. Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA.
Lungu C; Procopio FA; Overmars RJ; Beerkens RJJ; Voermans JJC; Rao S; Prins HAB; Rokx C; Pantaleo G; Vijver DAMCV; Mahmoudi T; Boucher CAB; Gruters RA; Kampen JJAV
Viruses; 2020 Sep; 12(9):. PubMed ID: 32887284
[TBL] [Abstract][Full Text] [Related]
4. Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1.
Bertoldi A; D'Urbano V; Bon I; Verbon A; Rokx C; Boucher C; van Kampen JJA; Gruters RA; Gallinella G; Calza L; Mahmoudi T; De Crignis E; Re MC
J Virol Methods; 2020 Feb; 276():113778. PubMed ID: 31756409
[TBL] [Abstract][Full Text] [Related]
5. Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay.
Châtel L; Yang X; Cholette F; Soudeyns H; Sandstrom P; Lavigne C
Arch Virol; 2018 Oct; 163(10):2701-2710. PubMed ID: 29882046
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Ignacio RAB; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 34841369
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Bender Ignacio RA; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N;
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 35544209
[TBL] [Abstract][Full Text] [Related]
8. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
9. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
Prodger JL; Lai J; Reynolds SJ; Keruly JC; Moore RD; Kasule J; Kityamuweesi T; Buule P; Serwadda D; Nason M; Capoferri AA; Porcella SF; Siliciano RF; Redd AD; Siliciano JD; Quinn TC
Clin Infect Dis; 2017 Oct; 65(8):1308-1315. PubMed ID: 28535179
[TBL] [Abstract][Full Text] [Related]
10. Improved assays to measure and characterize the inducible HIV reservoir.
Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
[TBL] [Abstract][Full Text] [Related]
11. Infectious Virus Persists in CD4
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
[TBL] [Abstract][Full Text] [Related]
12. A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection.
Frank I; Acharya A; Routhu NK; Aravantinou M; Harper JL; Maldonado S; Sole Cigoli M; Semova S; Mazel S; Paiardini M; Derby N; Byrareddy SN; Martinelli E
Sci Rep; 2019 Aug; 9(1):12078. PubMed ID: 31427605
[TBL] [Abstract][Full Text] [Related]
13. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.
Pardons M; Baxter AE; Massanella M; Pagliuzza A; Fromentin R; Dufour C; Leyre L; Routy JP; Kaufmann DE; Chomont N
PLoS Pathog; 2019 Feb; 15(2):e1007619. PubMed ID: 30811499
[TBL] [Abstract][Full Text] [Related]
14. Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA.
Lungu C; Banga R; Gruters RA; Procopio FA
Front Microbiol; 2021; 12():686690. PubMed ID: 34211450
[TBL] [Abstract][Full Text] [Related]
15. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
J Virol; 2019 May; 93(10):. PubMed ID: 30842333
[TBL] [Abstract][Full Text] [Related]
16. [Research advances in evaluation and measurement techniques of latent human immunodeficiency virus reservoirs].
Qihui Z; Biao Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(3):256-60. PubMed ID: 27651189
[TBL] [Abstract][Full Text] [Related]
17. CD161
Li X; Liu Z; Li Q; Hu R; Zhao L; Yang Y; Zhao J; Huang Z; Gao H; Li L; Cai W; Deng K
mBio; 2019 Oct; 10(5):. PubMed ID: 31594817
[TBL] [Abstract][Full Text] [Related]
18. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
19. Differences in inducibility of the latent HIV reservoir in perinatal and adult infection.
Dhummakupt A; Rubens JH; Anderson T; Powell L; Nonyane BA; Siems LV; Collinson-Streng A; Nilles T; Jones RB; Tepper V; Agwu A; Persaud D
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31999647
[TBL] [Abstract][Full Text] [Related]
20. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
